Blog
Breakthrough Treatments

Breakthrough Treatments

Discover cutting-edge psychiatric treatments like TMS, psychedelics, and novel treatments. Learn about their research, clinical applications, and real-world impact.

Compass Pathways Collaborates with Osmind to Advance Independent Clinic Readiness for Psychedelic Treatments

What the April 2026 Psychedelics Executive Order Means for Psychiatry

Osmind and CareNet GPO partner to make next-gen psychiatric treatments accessible and sustainable to independent psychiatry practices nationwide

Discounted SPRAVATO® Costs for Your Practice with CareNet GPO

How to Implement VNS Therapy™ in Your Practice: Patient Selection, Surgery, and Dosing

These Boots Are Made For Walking

GLP-1 Agonists Are Psychiatric Drugs. Psychiatry Should Start Acting Like It

When Standard Treatment Fails: New Evidence for VNS Therapy™ in Difficult-to-Treat Depression

How SPRAVATO® (esketamine) Helped Ben Finally See Himself Clearly

SPRAVATO J Code: What Clinicians Need to Know

Vagal Nerve Stimulation for Depression

Ketamine with TMS and Spravato Benefits

Osmind & Bendable Present Psilocybin Outcomes

SPRAVATO Consent Form Guide for Interventional Clinics

Portable TMS for Psychiatrists with Ampa

Scaling Psychiatric Impact with Force Multipliers

Transforming MDD Symptom Management with Digital Therapeutics

Clozapine REMS Program Ends Update

Implementing TMS for Adolescent Depression: Clinical Guide

The Ketamine Breakthrough: A Decade of Clinical Impact

ASKP3’s New Ketamine Therapy Standards

Ketamine Therapy for PTSD and MDD Findings

The SPRAVATO® Story: A Paradigm Shift in Depression Treatment

Cobenfy: New Era in Schizophrenia Treatment

Launching an Innovative Treatment Center

Psychiatrist’s Guide to Effective IV Ketamine Care

Dr. Feifel on Psychiatry’s Golden Era Now

Real-World Evidence for Esketamine in TRD

Esketamine vs IV Ketamine Depression Study

Evaluating TMS, ECT, Ketamine, and Esketamine for MDD

IV Ketamine Intake Documentation Guide

Legal Guidance to Protect Your Ketamine Clinic

Real-World Evidence for Ketamine Coverage

Vitals Monitoring for Ketamine Treatment

Autism, Ketamine & Restorative Justice MD

Clinical Trials and Breakthrough Psychiatry

Ketamine Treatment Outcome Model for MDD

Community Spotlight: Propel Therapeutics

7 Expert Predictions Shaping Psychiatry’s Future

Stella’s Acquisition of Field Trip Health Explained

IV ketamine note essentials for clinicians

Shaping Psychedelic Treatment Guidance Response

Dr. Tobias Marton on Scaling TRD Care

MDMA Legal Guidance for Mental Health Practices

Insights from Psychedelic Science 2023: Key Findings

Real world ketamine therapy study results

Top Psychedelic Science 2023 Sessions to Attend

Clinical TMS Society Meeting Highlights for Neuromodulation Care

Healing Potential of Psychedelic Therapy Insights

Psychedelic CPT Codes and Insurance Access Pathway

Denovo Therapy’s Mental Health Approach

Guide to Integrating SPRAVATO Treatment in Your Practice

Understanding Psychedelics with Dr. Boris Heifets!

Psychedelic Drug Interactions for Psychiatrists

Community Spotlight: Sonia Cotto Story

KOR Antagonists and Ketamine’s Mechanism in Depression

Future of Psychedelic Mental Health Care Guide

Giving Clinicians Time and Autonomy in Practice

Legal Updates for Psychedelic Medicine in 2023 Guide

Innovative Mental Health Care: Access & Insurance Barriers

Music’s Role in Psychedelic & Ketamine Therapy

Real-World Evidence for Ketamine Therapy

10 Credit Card Tips for Mental Health Practices

How Clinicians Start Sublingual Ketamine Therapy Safely

Community Spotlight: Ami Miller Story

Intro to Sublingual Ketamine Troches for Home Use

4 Ways Empower Ketamine Patients with MBC

Boosting ketamine therapy patient retention

Evidence From Ketamine and Related Compounds Conference

Two Essential Ketamine Studies Every Clinician Should Know

7 SPRAVATO Questions New Patients Ask You

Why Mental Health Practices Need Better EHRs

Malpractice questions for interventional psychiatry

A Patient’s Experience with Ketamine

Mental Health Support for First Responders

Solutions

CliniciansLife Sciences

Products

Osmind OneOsmind Care NetworkOsmind 360

Osmind

AboutCareersNewsResearch

Connect

Psychiatry CollectiveLinkedinInstagramYouTubeX

If you, or someone you know, is in crisis or needs immediate assistance, please call 911 immediately. To talk to someone now, please call the National Suicide Prevention Lifeline at 1-800-273-8255 or 988.

Osmind © 2026  All Rights Reserved.

Privacy PolicyTerms of Service